title

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

U.S. Food and Drug Administration, Center for Drug

1
Followers
0
Plays
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

U.S. Food and Drug Administration, Center for Drug

1
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) is an FDA podcast series that provides information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development.

Latest Episodes

FDA D.I.S.C.O.: FDA approval of Cablivi for acquired thrombotic thrombocytopenic purpura

FDA medical oncologists discuss the February 6, 2019, approval of caplacizumab-yhdp for acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.

-1 sAPR 12
Comments
FDA D.I.S.C.O.: FDA approval of Cablivi for acquired thrombotic thrombocytopenic purpura

FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur

In our inaugural podcast, Dr. Richard Pazdur, director of the FDA Oncology Center of Excellence, talks with hosts Dr. Sanjeeve Bala and Dr. Abhilasha Nair about this new podcast series.

-1 s2017 MAY 17
Comments
FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur
the END

Latest Episodes

FDA D.I.S.C.O.: FDA approval of Cablivi for acquired thrombotic thrombocytopenic purpura

FDA medical oncologists discuss the February 6, 2019, approval of caplacizumab-yhdp for acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.

-1 sAPR 12
Comments
FDA D.I.S.C.O.: FDA approval of Cablivi for acquired thrombotic thrombocytopenic purpura

FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur

In our inaugural podcast, Dr. Richard Pazdur, director of the FDA Oncology Center of Excellence, talks with hosts Dr. Sanjeeve Bala and Dr. Abhilasha Nair about this new podcast series.

-1 s2017 MAY 17
Comments
FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur
the END
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。